Table 1

Demographic characteristics and HLA-DR types of RA patients and controls

SexAgeDRB1RF
C1F24 *03 *11ND
C2F28 *09 *14ND
C3F30 *0401 *15ND
C4F31 *07 *15ND
C5M31 *01 *14ND
C6M32 *01 *09ND
C7F38 *03 *13ND
C8M53 *0401 *0405ND
C9F54 *12 *15ND
C10F58 *07 *12ND
C11F56 *13 *13ND
C12F73 *03 *11ND
R1F37 *0401 *0401Y
R2F40 *0401 *0404Y
R3F41 *0401 *07Y
R4M42 *07 *13N
R5F43 *0408 *0101Y
R6F56 *0401 *0401Y
R7F61 *0101 *13Y
R8F61 *13 *16Y
R9F63 *0405 *10Y
R10F63 *0401 *11Y
R11M63 *0401 *0101Y
R12F66 *0401 *11Y
R13F72 *0404 *0701Y
R14M75 *11 *14N
  • HLA-DRB1 genotypes (including HLA-DR4 subtypes) are shown for all controls (C1–12) and all patients with RA (R1-R14). The presence or absence of rheumatoid factor (RF) is indicated for all RA patients (ND indicates test not done in controls).